23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

      Journal of clinical oncology : official journal of the American Society of Clinical Oncology
      American Society of Clinical Oncology (ASCO)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To measure residual disease after neoadjuvant chemotherapy in order to improve the prognostic information that can be obtained from evaluating pathologic response.

          Related collections

          Author and article information

          Journal
          17785706
          10.1200/JCO.2007.10.6823

          Comments

          Comment on this article

          scite_